GLP-1 RAs approved by the US Food and Drug Administration (FDA) for T2DM and obesity (semaglutide, exenatide, liraglutide, tirzepatide, dulaglutide) were included in the analysis
Experience within Hoffmann La Roche
Factors such as your metabolism, hormonal balance, and pre-existing medical conditions could affect how well your body responds to the medication
Aberrant astrocytes cannot provide homoeostatic support, but instead generate reactive oxygen species that may mediate neurotoxicity
The coloration can vary from blue to red to brown
When there is sufficient reduced glutathione in the cells, they sacrifice themselves to free radicals to protect cellular mitochondria